Senior insider sale
President and CEO at TARSUS PHARMACEUTICALS, INC. — senior position signals high conviction
$1.56M
22.64K shares
What this filing means
AZAMIAN BOBAK R. plans to sell 22.64K shares of TARSUS PHARMACEUTICALS, INC. valued at approximately $1.56M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/18/2026ACC: 0001959173-26-002485
DirectorOfficer10% Owner· President and CEO
Since Oct 2020
22.64K
Shares to sell
$1.56M
Approx. market value
11.67K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
3/17/2026
11.67KTotal acquired11.67K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/17/2026 | Restricted Stock Vesting Compensation | 11.67K | — |
| Total | 11.67K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
10.97K
Market value
$761.6K
3/17/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
11.67K
Market value
$801.6K
3/18/2026
Total
Units
22.64K
Value
$1.56M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/17/2026 | 10.97K | $761.6K | — | Completed |
| Planned — Approximate Date | ||||
3/18/2026 | 11.67K | $801.6K | NASDAQ | Planned |
| Total | 22.64K | $1.56M | ||